News

News

World Expert in Genetics Joins Human Longevity as Chief Medical Officer

(SAN DIEGO) November 13, 2019 – C. Thomas Caskey, MD, FACP, FACMG, FRSC and Professor, Molecular & Human Genetics at the Baylor College of Medicine, leads HLI’s team to expand genetic assessments to worldwide client base Dr. Wei Wu He, Executive Chairman of Human Longevity, Inc., said, “Our clients will have the unique opportunity to Continue Reading

Continue Reading
News

HUMAN LONGEVITY CLOSES $30 MILLION FINANCING FROM EMERGING TECHNOLOGY PARTNERS AND OTHER LEADING HEALTHCARE INVESTORS TO RENEW ITS COMMITMENT TO LONGEVITY AND PRECISION HEALTH

SAN DIEGO, CA., November 6, 2019 — Human Longevity, Inc. (“HLI”), an innovator in providing data-driven precision health intelligence platform for physicians and patients, today announced a $30 million financing from veteran biotech investment firms and investors. Existing investor Emerging Technology Partners LLC participated in the financing with other new dedicated healthcare investors. HLI will Continue Reading

News

Researchers look beyond BMI to predict obesity-related disease risk

(SAN DIEGO) – October 11, 2018 – Scientists at Scripps Research and collaborating corporate and academic partners have found a new way to use distinct molecular “signatures” from people with obesity to predict risk of developing diabetes and cardiovascular disease, an advance that could broaden the way doctors and scientists think about diagnosing and treating disease. The Continue Reading

News

SCOR Global Life partners with Human Longevity, Inc. to bring data-driven health intelligence to life insurance policyholders

(SAN DIEGO) – August 29, 2018 – SCOR Global Life continues to promote health and wellness initiatives through a new partnership with Human Longevity, Inc. (HLI), an innovator in providing data-driven health intelligence to a broader range of consumers. HLI delivers individual health assessments by combining state-of-the-art DNA sequencing and expert analysis with machine learning. The Continue Reading

News

Human Longevity Appoints Dr. David Karow, M.D., Ph.D., as Interim Chief Executive Officer, Invigorating Company’s Vision to Drive Health Intelligence

Leadership Team Refined and Strengthened (SAN DIEGO) – July 13, 2018 – Human Longevity, Inc. (HLI), the genomics-powered, health intelligence company, announced today that David Karow M.D., Ph.D., has been appointed Interim Chief Executive Officer by the company’s Board of Directors. Serving most recently as HLI’s Chief of Radiogenomics, Dr. Karow has been a guiding force Continue Reading

Media Contact

Debbie Feinberg, VP Marketing
dfeinberg@humanlongevity.com

Media Resources

HLI Fact Sheet

Tweets